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INTRODUCTION
Several studies have consistently demonstrated the active
role of eosinophils in the development of nasal polyp (1-4).
An involvement of IgG, IgA and IgE has been suggested in
pathogenesis of nasal polyp (5) since these immunoglobulin
receptors can be found on the surface of eosinophil (6). Regard-
ing IgE-mediated mechanism in nasal polyp generation, there
have been a few studies demonstrating local production of
IgE within nasal polyp tissue (7, 8). Our previous study (9)
revealed that some non-atopic subjects by skin prick test result
had detectable specific IgE. However, they showed variable
results which may be derived from different study subjects and
atopy criteria (7-9). To the best of our knowledge, there has
been little attempt to elucidate the contribution of immuno-
globulins in eosinophil activation in nasal polyp tissue. 
In this study, to confirm local production of Dermatophagoides
pteronyssinus (DP)-specific IgE, we classified the study subjects
into three different groups according to of skin reactivity to
DP. To evaluate role of immunoglobulins on eosinophil acti-
vation we measured major immunoglobulins such as IgG,
IgA, sIgA, and IgE and DP-specific IgE levels as well as
eosinophil cationic protein (ECP) as eosinophil degranulation
product, in nasal polyp tissue homogenate in three different
groups, and observed the relationships between ECP and
immunoglobulins.
MATERIALS AND METHOD
Subject
Fifty-one subjects who had underwent nasal polypectomy
participated in this study and they were classified into three
groups according to skin reactivity to DP on skin prick test.
Group I consisted of 15 highly atopic subjects showing >3
mm wheal response to DP and group II consisted of 18 weakly
atopic subjects showing 1-3 mm wheal response to DP. Group
III consisted of 18 non-atopic subjects, who showed all neg-
ative responses to all common inhalant allergens on skin prick
test with serum total IgE level less than 100 IU/mL. The
polyps, soon after surgical removal, were washed with normal
saline to remove stagnant mucus. The middle portion of the
polyp was cut off and immediately sent to a pathology labo-
ratory to prepare the paraffin-embedded tissue block. Half
of them were made into tissue homogenate. All the subjects
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Role of IgG, IgA, and IgE Antibodies in Nasal Polyp Tissue
: Their Relationships with Eosinophilic Infiltration and Degranulation
To confirm local production of IgE, and evaluate role of immunoglobulins on eosi-
nophil activation in nasal polyp (NP) tissue, we measured IgG, IgA, secretory IgA
(sIgA), total (tIgE) and specific IgE (sIgE) to Dermatophagoides pteronyssinus
(DP) by ELISA in NP tissue homogenates from 51 subjects. They were classi-
fied according to skin reactivity to DP: group I, 15 highly atopic subjects; group
II, 18 weakly atopic subjects; and group III, 18 non-atopic subjects. Eosinophil
cationic protein (ECP) level was measured by CAP system. Highest level of DP-
sIgE was noted in group I, followed by group II and III (p<0.05). Nine (60%) of
group I and 4 (22%) of group II subjects had detectable level of DP-sIgE with no
significant differences in IgA, sIgA, and IgG. All of NP tissue had eosinophilic infil-
tration with no significant difference in activated eosinophil count or ECP level
among 3 groups. A significant correlation was noted between EG2+ cell count
and tIgE (r=0.55, p<0.05), and DP-sIgE level (r=0.60, p<0.05). A significant cor-
relation was also noted between ECP and IgG (r=0.51, p<0.05) and DP-sIgE
level (r=0.47, p<0.05) with no significant correlation with IgA or sIgA. These results
suggest that DP-sIgE was detectable in NP tissue from weakly atopic subjects
as well as highly atopic subjects. IgG and sIgE may have potential roles in eosi-
nophil degranulation in NP tissue.
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gave their informed consent as regulated by the institutional
review board of Ajou University Hospital, Suwon, Korea.
Preparation of nasal polyp tissue, measurement of ECP
and albumin level
The polyp tissues were frozen at -70℃ immediately after
the operation. To be prepared for the experiments, the sam-
ples were thawed and grounded in a homogenizer (POLY-
TRON, Switzerland) with phosphate buffered saline (PBS,
pH 7.5) including 1% Triton X 100. They were centrifuged
and the separated supernatants were kept at -70℃until the
measurement of ECP, albumin and immunoglobulin levels on
the same day. ECP level in nasal polyp tissue homogenate was
measured using CAP system (Pharmacia, Sweden) and albu-
min level was measured by nephelometry. All values were
presented as ratio to albumin level.
Measurement of total IgG and IgA within polyp tissue
homogenate
Microtiter plates were coated with 50  L of anti-IgG or
anti-IgA antibodies (Sigma, St. Louis, MO) at 2  g/mL con-
centration and kept overnight at 4℃. After the washing step,
the plates were blocked with PBS with 3% bovine serum
albumin and 0.05% Tween 20. They were incubated with
serial dilutions of duplicate sample of tissue homogenate
(50  L/well) or immunoglobulin standard (The binding site,
Birmingham, U.K.) for 2 hr at 4℃. After washings, the plates
were incubated with peroxidase conjugated affinity-purified
goat anti-IgG and anti-IgA antibodies (Sigma, St. Louis, MO,
U.S.A.) at 1:2,500 dilution (v/v) for 1 hr at room temperature.
After washing, we added a substrate solution that consisted of
0.04% w/v o-phenylene diamine dissolved in 24.3 mM cit-
ric acid, 51.4 mM NaH2PO4(pH 5.0) and 0.03% H2O2. After
15 min, the reaction was stopped by adding 2.5 N H2O4.
Amounts of total IgG and IgA antibodies in samples were
calculated from control curves prepared by optical densities
from serial dilutions of immunoglobulin standard solution
using a spline fit program (SoftMax, Molecular Devices).
Measurement of total sIgA within polyp tissue homo-
genate
Microtiter plates were coated with 50  L of anti-secretory
piece antibodies (The binding site, Birmingham, U.K.) in 0.1
M carbonate buffer at 2  g/mL concentration and kept over-
night at 4℃. After the washing step, the plates were blocked
with PBS with 3% bovine serum albumin and 0.05% Tween
20. They were incubated with serial dilutions of duplicate
sample of tissue homogenate (50  L/well) or purified sIgA
(The binding site, Birmingham, U.K.) for 2 hr at 4℃. After
repeated washings, the plates were incubated with biotiny-
lated affinity-purified goat anti-IgA antibody (Sigma, St.
Louis, MO) at 1:2,500 dilution (v/v) for 1 hr at room tem-
perature. After another washing step, the plates were incu-
bated with streptavidin-peroxidase (0.5  g/mL) for 30 min
at room temperature. Then we added o-phenylene diamine
as a substrate solution. The absorbance at 490 nm was mea-
sured by microplate reader (Molecular device, CA, U.S.A.)
and the amounts of sIgA were calculated as described above.
Measurement of total and specific IgE to DP in polyp
tissue homogenate
The levels of total IgE in polyp tissues were measured by
sandwich ELISA as described previously (7). Microtiter plates
(Immulon II; Dynatech Laboratories, Inc., Chantilly, VA,
U.S.A.) were coated with 50  L of affinity-purified goat anti-
IgE antibody (Vector Laboratories, Inc., Burlingame, CA,
U.S.A.) at 1:500 dilution (1  g/mL) with 0.1 M carbonate
buffer, pH 9.6, for 2 hr at 4℃. After the washing step, the
plates were blocked with PBS with 3% bovine serum albu-
min and 0.05% Tween 20. The plates were incubated with
dilutions of duplicate samples of polyp tissue homogenate.
After washings, the plates were incubated with biotinylated
affinity-purified goat anti-IgE antibody (Vector Laboratories,
Inc., Burlingame, CA) at 1:500 dilution (1  g/mL) for 1 hr
at room temperature. After another washing step, plates were
incubated with streptavidin-peroxidase (0.5  g/mL) for 30 min
at room temperature. After washing, we added o-phenylene
diamine as a substrate solute and the absorbance was mea-
sured by a microplate reader. The absolute level of total IgE
in the sample was calculated from the curve derived from
serial dilutions of IgE standard (DPC, LA, CA). All samples
were measured simultaneously to reduce possible variations
in measurements.
For the measurement of DP-specific IgE, the procedure was
essentially the same as in the above method except the mi-
crotiter plates were coated with DP (2  g/well, Allergophar-
ma, Germany) instead of anti-IgE antibody, and a fixed sam-
ple dilution was used (1:50 dilution in blocking buffer). Pos-
itive cut-off value for specific IgE was determined as mean
+2 folds of standard deviation of the absorbance values from
the group III subjects.
Staining procedures
Four-micrometer thick tissue sections were stained with
each monoclonal antibody to activated eosinophils. The anti-
bodies were applied at optimal dilutions with Tris-buffered
saline, which were determined by the previous titration exper-
iments (2, 3). After deparaffinization and hydration, sections
were incubated with 10% normal goat serum to block non-
specific binding. Then, they were incubated overnight with
primary antibodies at 1:200 dilution (EG2, Pharmacia, Sweden)
at room temperature. A streptavidin-biotin complex (Dako,
Denmark) detection system with aminoethylcarbazole as chro-Specific Antibodies and Eosinophil in Nasal Polyp 377
mogen was used, and sections were counter-stained with
Meyer’s hematoxylin. For negative control, the primary anti-
body was omitted.
Evaluation
The sections were evaluated with conventional light mi-
croscopy (×100, ×200, ×400). The number of stained cells
were counted and presented as cells/mm2 of tissue area as
reported in our previous study (2, 3). Four areas per tissue
were estimated by superimposing a grid of 100 points (inter-
section of crosses, covering a surface area of 0.5 mm2) on the
section and by using an eyepiece graticulate at a magnification
of×200. The mean cell count was derived from the sum of
the four fields.
Statistical analysis
ANOVA and Student t tests were applied using the SPSS
version 7.0 (Chicago, IL) to evaluate the statistical differences
among the data. Pearson’s correlation analysis was applied
to evaluate the statistical significance between two values:
A p value of 0.05 or less was regarded as significant. 
RESULTS
IgA, sIgA, and IgG levels in nasal polyp tissue
Fig. 1 shows the comparison of each immunoglobulin con-
centration in nasal polyp tissue homogenate presented as its
ratio to albumin ( g/mg/mL). IgA/albumin (1,215.7±905.7
g/mg/mL) showed the highest level, followed by IgG/albu-
min (335.6±273.7 g/mg/mL), and sIgA/albumin (137.1
±192.8  g/mg/mL) and a significant correlation was found
between IgA and sIgA levels (r=0.80, p<0.05). There was no
significant difference in IgA, sIgA, IgG and albumin levels
among the three groups (p>0.05, respectively). 
Comparison of total and DP-specific IgE among the
three groups
Fig. 2 shows comparison of total IgE level in both polyp
tissue homogenate and sera of the three groups. Total IgE
level of group I in both serum and polyp tissue was signifi-
cantly higher than in group II and group III (p<0.05, respec-
tively). Moreover a significant difference was noted between
group II and III (p<0.05). Fig. 3 shows the comparison of
DP-specific IgE level in the three study groups. Nine (60%)
subjects of group I and four (22%) of group II had high specif-
ic IgE antibody. Specific IgE level of group I was significantly
higher than that of group II or group III (p<0.05, respective-
ly). A significant difference was noted between group II and
III (p<0.05).
Relationship between ECP and three immunoglobulin
levels in nasal polyp tissue
No significant correlation was found between EG2+cell
count and ECP level (p>0.05, data was not shown). Although
there was no significant correlation between ECP and IgA,
sIgA or total IgE level, significant correlations were noted
between ECP and IgG (r=0.51, p<0.05, Fig. 4A), and DP-
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Fig. 2. Comparison of the total IgE (tIgE) levels in nasal polyp tissue
(●) and serum (○) of the three study groups. The values are pre-
sented as the ratio of the total IgE level to albumin. Horizontal bars
indicate mean values. Significant differences are noted between
the two groups by Student t-test (p<0.05). 
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Fig. 1. The ratios of IgG, IgA, and secretory IgA (sIgA) to albumin
in nasal polyp tissues from the study subjects. Significant differ-
ences are noted between IgA/albumin and IgG/albumin, and
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specific IgE (r=0.55, p<0.05, Fig. 4B) in nasal polyp tissue.
When group I subjects were separated, higher correlation
coefficent was noted between ECP and DP-specific IgE (r=
0.62, p<0.05), and IgG (r=0.76, p<0.05) levels.
Relationship between EG2+ cell count and IgG, IgA,
or IgE level
A significant correlation was found between EG2+ cell
count and total IgE (r=0.55, p<0.05) and DP-specific IgE
in nasal polyp (r=0.60, p<0.05 data was not shown). Poor
correlations were found with IgA (r=-0.05), sIgA (r=-0.29)
and IgG (r=-0.11, p>0.05, respectively).
DISCUSSION
Studies of inflammatory cells infiltrating nasal polyps have
shown that they consist of mast cells, eosinophils, lymphocytes,
and neutrophils and most authors have found a consistent
infiltration of stroma with eosinophils (1-3) whose numbers
are reported to be higher than those of mast cells. In accor-
dance with previous observations (10, 11), we have found
that the infiltrate is, in many respects, similar to that of the
bronchial mucosa of atopic asthmatics in that eosinophilia
was a consistent feature. Our previous study (2) showed that
EG2+cells were abundant in both epithelial and stromal
layers of patients with nasal polyp, irrespective of whether they
were atopic or nonatopic. In this study, all the subjects had
EG2+cells and no significant differences existed in EG2+
cell count among the three groups. However, EG2+cell
numbers tended to be higher (2) in nasal polyps from allergic
subjects than from non-allergic subjects, indicating activat-
ed eosinophils could participate in the generation of nasal
polyps in both allergic and non-allergic groups. 
Although the role of atopy in development of nasal polyp
has been unclear, some studies (12, 13) have reported that
60-66% of patients who had underwent nasal polypectomy
have had positive skin prick tests to common aeroallergens,
suggesting an association (9, 14, 15) between atopy and nasal
polyp. Other studies including our previous study, suggested
that the IgE-mediated mechanism may be present in subpop-
ulation of patients with nasal polyposis.
In this study, to confirm local production of IgE in nasal
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Fig. 4. Correlation between eosinophil cationic protein (ECP) level, and IgG (A) and specific IgE antibody to Dermatophagoides pteronyssi-
nus (B) in nasal polyp tissues from the study subjects.
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Fig. 3. Comparison of the Dermatophagoides pteronyssinus-spe-
cific IgE levels in nasal polyp tissue of the three study groups.
Horizontal bars indicate mean values. Significant differences are
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polyp tissue, we classified the study subjects into three groups
according to their skin reactivity to house dust mite: highly
atopic, weakly atopic and non-atopics, and compared IgG,
IgA, sIgA, total and specific IgE levels to house dust mite in
nasal polyp tissue homogenate. There were no significant dif-
ferences in IgA, sIgA and IgG levels among the three groups.
However, there was significant difference in total and specific
IgE levels. Interestingly, some weakly atopic subjects had
high specific IgE in nasal polyp tissue, while none of group
III had specific IgE. Both total and specific IgE levels in nasal
polyp tissue were significantly higher in weakly atopic than
in non-atopic subjects. These findings suggest that total and
specific IgE antibodies are locally produced within the nasal
polyp tissue in some weakly atopic subjects as well as highly
atopic subjects. Both atopics and non-atopics produce IgG,
IgA, and sIgA in nasal polyp tissue. These immunoglobulins
may contribute to inflammatory responses occurring in nasal
polyp tissue.
Regarding the role of immunoglobulins (IgA, IgE and IgG)
in eosinophil activation, they can stimulate eosinophil degran-
ulation, resulting in the release of cytotoxic proteins such as
ECP, eosinophil peroxidase and eosinophil-derived neutrophils
in vitro condition (16). IgA, particularly sIgA, has been shown
to mediate eosinophil degranulation in vitro (17), and increased
expression of IgA receptors on eosinophils of allergic indi-
viduals has been reported (18). Recent studies have impli-
cated IgG or IgA as a contributor of allergic inflammation of
asthmatic airways (18, 19). Bronchoalveolar lavage (BAL)
fluids from asthmatic subjects allergic to ragweed could lead
to a degranulation of eosinophils in vitro, and the degree of
degranulation correlates with the levels of antigen-specific
IgA, IgG, and IgG1 found in those fluids (20). These results
suggest that these immunoglobulin isotypes may mediate
eosinophil degranulation in an antigen-specific fashion. 
Peebles et al. (21) found significant correlations between the
levels of ECP in BAL fluid after segmental lung challenge
(SLC) and the levels of ragweed-specific IgA both in serum
and BAL fluid after SLC, while there was no correlation be-
tween the concentrations of ragweed-specific IgA in the pre-
SLC BAL fluids and ECP. However, another study revealed
that there was a poor correlation between ragweed-specific
IgA levels in either serum or in BAL fluid in antigen-chal-
lenged segment and total eosinophil numbers, suggesting
that antigen-specific IgA is not involved in eosinophil recruit-
ment. The present study is the first to observe the relationship
between IgG, IgA, and sIgA antibodies within nasal polyp
tissue and EG2+cells or ECP as eosinophil degranulation
product. This study also showed that IgA was the most abun-
dant immunoglobulin in nasal polyp tissue compared to other
immunoglobulins with a significant correlation between IgA
and sIgA. Because of its abundance in nasal polyp tissue, IgA
antibody may be one of major immunoglobulin isotype in-
volved in eosinophil degranulation. However, in this study,
no significant correlations were noted between ECP or EG2+
cell count and IgA or sIgA in nasal polyp tissue. Instead,
significant correlations were noted between ECP and IgG,
and DP-specific IgE, which were comparable to the previous
study (22). Furthermore, a higher correlation coefficient was
found between ECP and IgG in highly atopic subjects. These
findings may be attributable to the fact that the IgA and sIgA
measured in this study was total IgA and sIgA, not allergen-
specific IgA, sIgA and IgG. Our results support the hypoth-
esis that IgG antibody may be involved in the eosinophil
degranulation found in nasal polyp inflammation.
Recent investigations in BAL study from allergic asthma
patients have demonstrated that ragweed-specific IgE is most
strongly correlated with ECP release (21) and it has been re-
ported that IgE receptors are present on eosinophils (23, 24).
However, an in vitro study revealed that IgE or anti-IgE did
not induce any direct effector function such as leukotriene
C4, superoxide production or any degranulation product (25).
To date, the mechanism of IgE-mediated eosinophil degran-
ulation has been unclear. This is the first study to observe the
relationship between ECP and EG2+cell count, and total
and DP-specific IgE levels in nasal polyp tissue. In this study,
a significant correlation was found between ECP and DP-
specific IgE, and furthermore, a higher correlation coefficient
was noted between ECP and specific IgE in highly atopic
subjects. Moreover, a significant correlation was found be-
tween EG2+cell count and total and DP-specific IgE levels
in nasal polyp tissue. These findings suggest that IgE may
be involved in eosinophil recruitment and priming as well
as eosinophil degranulation in nasal polyp tissue.
In conclusion, the results from this study suggested a pos-
sible involvement of immunoglobulins such as IgG and
allergen-specific IgE in degranulation and/or recruitment of
eosinophils in nasal polyp tissue. Further investigations are
needed to clarify the exact mechanism of IgG- or IgE-medi-
ated eosinophil degranulation and/or recruitment occurring
in nasal polyp tissue.
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